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emphasis on partnerships, decision-making by African
scientists, and a strong scientific basis for the funded
research. To support a variety of research programs, MIM has
also developed the Malaria Research and Reference Reagent
Resource Center, which provides high quality reagents and
materials to investigators who are, or wish to be, involved in
malaria research. NIH’s National Library of Medicine has
taken responsibility for enhancing the capacity of African
scientists to do research by establishing and supporting
access to communications and information resources. A
number of research networks are online using very small
aperture telecommunications (VSAT) technology for Internet
access. This allows for shared databases, electronic mail and
discussion groups, access to published literature, and use of
remote sensing technologies. Information about the progress
of MIM is shared through meetings, a newsletter, and on the
internet at http://mim.nih.gov
Future goals of MIM include stabilizing funding for the
MIM-TDR grant program, developing new partnerships, and
creating new training opportunities, such as training on
research management. Scientific research on Plasmodium
vivax  and on malaria-related anemia is being conducted.
Interactions with RBM are well-established and coordinated.
The 2nd International MIM Conference is scheduled for 2002
in Tanzania.
Institutional review boards (IRBs) play an essential
role in protecting the rights of volunteers involved in
research projects. Their function has become more complex,
particularly concerning projects conducted in developing
countries. But can IRBs in the United States guarantee the
protection of human subjects involved in research projects
in developing countries?
IRBs have no effective way of controlling what goes on in
the field. The complex ethical clearance process does not
determine whether persons engaged in research projects in
developing countries are fully aware of the major aspects of
the studies they participate in. The clearance process includes
the IRB approval and consent forms. Required U.S. consent
forms are too long and the language too complicated to be
certain all participants have a full understanding of the
study. The forms also appear to be intended more to offer legal
protection to sponsoring agencies than to protect the welfare
of the volunteer. Most importantly, the forms do not
guarantee that volunteers have fully understood the
objectives, risks, and benefits of the study and the extent of
their voluntary participation. To protect volunteers as well as
all persons and institutions involved, these forms must not
only communicate necessary information concerning the
study to be conducted but also evaluate volunteers’ knowledge
and their desire to participate. To achieve this goal, we propose
to use a simple questionnaire administered by a team not
involved in the volunteer recruitment process. We have used
such a questionnaire to evaluate potential volunteers for a
phase-II HIV vaccine trial. Although volunteers had three
intensive, 2-hour counseling sessions, only half responded
correctly to all 21 questions. The others were referred for
additional counseling and reevaluation.
The IRB process requires that collaborative projects with
U.S. institutions have clearance from multiple IRBs. Each
IRB meets generally once a month and uses its own consent
forms. Each has its own set of rules. Each will respond with
different concerns that must be addressed. The approval
process may create a lag time of 3 to 12 months to obtain
ethical clearances for a project lasting 12 to 24 months.
The ethical clearance process can be simplified in several
ways: 1) All studies supported by NIH should have a unique
IRB application form and a unique IRB consent form. 2) A
certain percentage of the research grant should be allocated to
support the ethical clearance process. Ethical support should
be available at the grant’s initiation. 3) While waiting for the
formal ethical clearance and final consent, potential
volunteers could be counseled and evaluated. 4) The primary
responsibility of local and national IRBs should be clearly
determined. IRBs must share responsibilities to achieve the
greatest benefit for volunteers. 5) A mechanism must be
developed to resolve conflicts between IRBs from developed
and developing countries. Yearly meetings of IRBs from host
and sponsoring institutions should take place to facilitate the
exchange of documents and other information.
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